Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors.
Maja Zupančič *Department of Molecular Neurosciences, Center for Brain Research, Medical University of Vienna, Vienna, Austria.
Erik Keimpema *Department of Molecular Neurosciences, Center for Brain Research, Medical University of Vienna, Vienna, Austria. Erik.Keimpema@meduniwien.ac.at.ORCID 0000-0002-7555-6762
Evgenii O TretiakovDepartment of Molecular Neurosciences, Center for Brain Research, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-5920-2190
Stephanie J EderDepartment of Neuroscience and Developmental Biology, Vienna Biocenter (VBC), University of Vienna, Vienna, Austria.ORCID 0000-0002-2061-5382
Itamar LevDepartment of Neuroscience and Developmental Biology, Vienna Biocenter (VBC), University of Vienna, Vienna, Austria.
Lukas EnglmaierCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID 0000-0002-0082-2616
Pradeep BhandariInstitute of Science and Technology Austria, Klosterneuburg, Austria.ORCID 0000-0003-0863-4481
Simone A FietzInstitute of Veterinary Anatomy, Histology and Embryology, University of Leipzig, Leipzig, Germany.ORCID 0009-0005-1944-6381
Wolfgang HärtigPaul Flechsig Institute for Brain Research, University of Leipzig, Leipzig, Germany.
Estelle RenauxAnimal Molecular and Cellular Biology, Louvain Institute of Biomolecular Science and Technology, Université catholique de Louvain, Louvain-la-Neuve, Belgium.ORCID 0009-0008-2244-8160
Andreas VillungerCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID 0000-0001-8259-4153
Tomas HökfeltDepartment of Neuroscience, Biomedicum 7D, Karolinska Institutet, Solna, Sweden.ORCID 0000-0002-3587-0116
Manuel ZimmerDepartment of Neuroscience and Developmental Biology, Vienna Biocenter (VBC), University of Vienna, Vienna, Austria.
Frédéric ClotmanAnimal Molecular and Cellular Biology, Louvain Institute of Biomolecular Science and Technology, Université catholique de Louvain, Louvain-la-Neuve, Belgium.ORCID 0000-0002-0497-2195
Tibor HarkanyDepartment of Molecular Neurosciences, Center for Brain Research, Medical University of Vienna, Vienna, Austria. Tibor.Harkany@meduniwien.ac.at.ORCID 0000-0002-6637-5900
Funding
Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Ann E. Rougvie · 2012 to 2026
$7.5M
Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) P 34121-BEC | EC Seventh Framework Programm | FP7 Ideas: European Research Council (FP7-IDEAS-ERC - Specific Programme: "Ideas" Implementing the Seventh Framework Programme of the European Community for Research, Technological Development and Demonstration Activities (2007 to 2013)) ERC-2020-AdG-101021016NIH HHS P40 OD010440Novo Nordisk Fonden (Novo Nordisk Foundation) NNF20OC0053667Vetenskapsrådet (Swedish Research Council) 2018-02838
6 · The paper itself
Abstract
Acquisition of specialized cellular features is controlled by the ordered expression of transcription factors (TFs) along differentiation trajectories. Here, we find a member of the Onecut TF family, ONECUT3, expressed in postmitotic neurons that leave their Ascl1
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Concerted transcriptional regulation of the morphogenesis of hypothalamic neurons by ONECUT3. · full record | OpenQuestion